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Background: Drugs photostability plays two different opposite roles; a real advantage arises considering the longer
expiration time of the drugs while the consequent persistence in the environment involves an obvious negative
effect bound to their harmfulness.
On this basis we tested the photostability and toxicity of three pharmaceutical active principles: Finasteride,
Diclofenac and Naproxen. The pure active principles, as well as commercial drugs containing them, were
considered; for the last, the protective effect of the packaging was also evaluated. Samples were irradiated
according to the ICH Guidelines for photostability testing (The International Conference on Harmonisation of
Technical Requirements for Registration of Pharmaceuticals for Human Use); a simulating sunlight source
(a mercury-vapor lamp coupled to a tungsten filament one) was used to cover the wavelength range
300–2000 nm; Temperature, Relative Humidity, Irradiance and Illuminance were maintained constant during the
photodegradation. The concentrations of the pharmaceutical active principles during the photodegradation were
monitored by HPLC with UV/Vis detector. Toxicity tests were performed by means of an amperometric biosensor based
on suspended yeast cells. Since the products obtained by the photodegradation process can result as toxic or more
toxic than the original molecules, tests were performed first and after the photodegadation.
Results: After 90 hours of exposure the concentration resulted lowered by 42.9%, 88.4% and 91% for Finasteride,
Naproxen and Diclofenac respectively. Toxicity of the pure active principles follows the same order of the
photostability. After photodegradation a contribute of the reaction products was evidenced.
Conclusions: The simple and cheap analytical procedure here proposed, allowed to obtain not only data on
photostability and toxicity of the pure active principles but, even if roughly, also useful information on the
reactions kinetic and toxicity of the photodegradation products.
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From several years it is well known [1] that many com-
pounds, including drugs, are photoreactive. In the past,
the topic received scarce attention due to the incorrect be-
lief that the packaging could protect the active principle so
avoiding its photodegradation [2]. This led to a limited
knowledge of the phenomenon until relatively recent time.* Correspondence: mariapia.sammartino@uniroma1.it
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distribution, and reproduction in any mediumThe European Pharmacopoeia [3] states that a drug must
be opportunely protected from the exposure to the light in
order to avoid a reduction of the active principle concen-
tration with a consequent lost of efficiency. Photodegrada-
tion was then recognized as an important limiting factor
of the shelf life of a drug that can be greatly influenced by
its wrong storage and/or handling. Thus not only quality
control laboratories, but also international organization
(like WHO) [4] and pharmaceutical companies [5,6] are
interested in the development of a valid protection toCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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radation products could be more toxic than the starting
reagents causing side effects on humans and producing
unknown biological effects and new risks for ecosystems.
With the introduction of ICH guidelines [7] for carrying
out photostability tests on drugs, researchers have deep-
ened studies on the topic and several drugs were individu-
ally examined [8,9]; on the contrary, comparative studies
on different drugs are still scarce. Such comparison can
allow to obtain a scale of stability/recalcitrance (environ-
mental persistence) of similar or different pharmaceutical
formulations useful for solving ecopharmacology problems
[10] (studies of the interaction between the environmental
compartments and drugs for human and animals, products
for personal care, for hospital cleaning, disinfectants, anti-
bacterials). Here, we present a research aiming to compare
the photostability of three active principles chosen among
the most consumed in Italy [11]: Naproxen [12,13], Diclo-
fenac [14,15] and Finasteride [16] (Additional file 1: Figure
S1). The first two are well-known anti-inflammatory active
principles while the third one is an inhibitor of 5-alpha-
reductase (it inhibits the reaction of testosterone to
dihydrotestosterone) and it is commonly used for the treat-
ment of prostatic hypertrophy and androgenetic alopecia.
Photodegradation tests were carried out using an irradi-
ation source simulating sunlight (see Experimental
paragraph). The photodegradation products were not
determined because of their possible large number; we
preferred to correlate their formation during the deg-
radation with the toxicity trend. Really such data can be
more useful since they take into account synergic effect
of both the residual drug and all the photodegradation
products. The active principles were determined by HPLC
using UV/Vis detection. Absorption spectra of the pure
molecules (Additional file 1: Figure S2) were recorded in
order to set the detector for the chromatographic analysis
at the most suitable wavelength. Active principles were
subjected to photodegradation as pure molecules (mostly
dissolved in water), and as solid pharmaceutical forms; in
the last case, they were exposed inside the marketind pack
as well as inside and outside the immediate pack, in order
to evaluate eventual differences in the protection ability.
Kinetic parameters for the photodegradation reaction were
determined for the pure molecules dissolved in aqueous
solution. The Integral Toxicity Index (before and after
their exposure to the simulated sunlight) was obtained by
means of an amperometric biosensor [17] based on sus-
pended yeast cells.
Results and discussion
The accuracy of the analytical procedure adopted for the
three drugs was evaluated considering as “true value” the
concentration of the active principle declared by the pro-
ducers; good inaccuracy values resulted, i.e. below thelegal limits set for the title printed on the package [18].
Data are reported in Table 1, where also the precision of
the measures can be evaluated.
In order to study the photodegradation kinetic and to
optimize the chromatographic parameters we started with
the analyses of the pure active principles. The choice of
the initial concentration has followed the criterion to fall
inside the linearity range of both the spectrophotometric
and HPLC methods. On this base about 10-3 mol/l aque-
ous solution were used.
Figures 1, 2 and 3 show the chromatograms obtained
for the solutions of the three pure active principles dur-
ing the photodegradation.
The retention time of Finasteride (Figure 1) is 5′ 25″.
The chromatographic peak decreases enough slowly (about
50% at the end of the test) and no other detectable peaks
at the fixed wavelength appear. This could means that the
basic structure is destroyed during the photodegradation
and the formed fragments, with absorption at different
wavelength, are less recalcitrant so that they undergo
photodegradation preferentially, compared to Finasteride.
In the case of Diclofenac (Figure 2), having a retention
time of 6′ 30″, the chromatographic peak decreases
enough quickly during the first 30 hours (about 60%) and
then the process slows reaching a photodegradation per-
centage of about 85%. With a similar speed trend, peaks of
the reaction products appear in the chromatogram at lower
retention times (between 3 and 5 minutes). In particular
the peak at 4′ 20″ increases up to reach the maximum
after 30 hours of degradation, and then remain constant
up the end of the experiment. This could indicates that,
after 30 hours, this product also undergoes degradation
and concentration remains almost constant as a conse-
quence of a similar speed of formation from Diclofenac
and photodegradation. More, the appearance of peaks with
absorption at the same wavelength can mean that the basic
structure remains intact in the first phase of the process, in
agreement with its aromatic nature.
In comparison with the previous two, Naproxen (re-
tention time of 4′ 45″) undergoes a very quick photode-
gradation (Figure 3); after 30 hours of irradiation its
chromatographic peak becomes not detectable. A peak at
retention time equal to 5′ 30″ quickly increases reaching
its maximum after 15 hours of irradiation and then just as
quickly decreases indicating that also its photodegradation
starts. Other smaller peaks appears between the 2′ 50″ to
4′ 35″, also attributable to the formation of degradation
products, they become significant after 20 hours and
remained almost constant up the end of the test. The
same considerations made for the Diclofenac may be valid
for Naproxen, the largest number of peaks is consistent
with its naphthalenic structure.
In Table 2 the retention times of the three active princi-
ples and of their photodegradation products are listed.
Table 1 Inaccuracy evaluated for the analysis of the three drugs
Drug (tablets) Active principle Declared concentration (mg) Found concentration (mg) ± SD Inaccuracy (%)
Voltaren 50 Diclofenac sodium salt 50 51.8 ± 0.2 + 3.6
Momendol 220 Naproxen sodium salt 220 225.5 ± 3.4 + 2.5
Prostide Finasteride 5 5.16 ± 0.07 + 3.2
Data come from at least 3 measures.
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method to follow the photodegradation trend, we are un-
able to recognize the reaction products and to fully under-
stand the kinetic pattern; anyway, taking into account the
formula structures, the noticeable differences in the chro-
matograms allow us to make some assumptions.
Figure 4, where average concentration values vs. expos-
ure time are reported, shows that, for Finasteride and
Diclofenac, the trend lines reveal a first order kinetic (Ct =
C0 · e
-kt) during all the exposition time (R2 = 0.9850 for Fi-
nasteride and R2 = 0.9962 for Diclofenac). The half-life
time (t1/2 = (ln2)/k) results to be 106.6 and 24.2 hours for
Finasteride and for Diclofenac respectively.
Naproxen trend follows the same kinetic equations
only during the first 30 hours of irradiation, probably, as
above said, this must be ascribed to the simultaneous
photodegradation of its degradation product. In the first
part, the decay curve fits a first order equation with an
enough good correlation coefficient (R2 = 0.9855); basing
on it, the half-life time results equal to 10.0 hours.
Toxicity tests were carried out, first and after the
photodegradation tests, using yeast cell and a Clark oxy-
gen electrode (see Experimental paragraph).Figure 1 Chromatograms of Finasteride at different irradiation time. I
eluent: Acetonitrile/Water 95:5; Alltech Alltima C8 5 μm, 250 mm x 4 mm ØTable 3 shows that, for the three pure principles, the ini-
tial toxicity follows the order Naproxen =Diclofenac > Fi-
nasteride while at the end of the tests the order results D >
F >N with a toxicity decrease in all the cases. The toxicity
decreases can be better understood basing on Figure 5
where the percentage reduction of the toxicity indexes (ItR)
are compared with the photodegradation percentages
(PDE). The ItR follows the same trend of the PD but, really,
the percentages toxicity reduction always results lower than
the photodegradation percentage; this means that surely
the photodegradation products are also toxic even if at a
lower extent respect to the corresponding drugs.
Results of the photostability tests are summarized in
Figure 6. It can be seen that the photostability order is
Finasteride > >Diclofenc >Naproxen for both the pure ac-
tive principles and drugs containing them. In the last case
the difference between Diclofenac and Naproxen is signifi-
cantly higher with respect to the pure active principles. As
expected, their persistence in the environment is signifi-
cantly lower in aqueous solutions. Surely this is due to a
physical protective effect of excipients; as a fact, the single
molecules of active principles results differently exposed de-
pending on the different position inside the powder grainsnitial concentration: 9.992.10-4 mol/l in 1:20 Acetonitrile/Water solution;
; flow: 1 ml/min.
Figure 2 Chromatograms of Diclofenac at different irradiation time. Initial concentration: 3.003.10-3 mol/l in water; eluent: pH 3.3 phosphate
buffer/Acetonitrile/Methyl alcohol 30:35:35; Alltech Alltima C8 5 μm, 250 mm x 4 mm Ø; flow: 1.25 ml/min.
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thin layer as suggested by ICH guideline). Furthermore,
other organic compounds contained in the drug can com-
pete with the active principles during the photodegradation.
For all the three drugs, the marketing package (cardboard)
ensures a good protection against photodegradation while,
as expected, the protective efficiency of the primary pack-
age is significantly lower. Since we chosen to follow the
ICH guidelines, the differences in photostability between
the drug naked and inside the primary packaging could beFigure 3 Chromatograms of Naproxen at different irradiation time. In
buffer/Acetonitrile/Methyl alcohol 30:35:35; Alltech Alltima C8 5 μm, 250 mnot significant due to the differences of exposed area and
thickness.
Experimental
Choice of the light source for the photodegradation
Several measures of irradiance and radiant energy were
performed on the terrace of the Chemistry Department of
Rome “La Sapienza” University; some sunny days were
randomly chosen in the months of May, June and July.
Relying on these data and complying with ICH guidelines,itial concentration: 4.893.10-3 mol/ l in water; eluent: pH 3.3 phosphate
m x 4 mm Ø; flow: 1 ml/min.
Table 2 Retention time of the three active principles and
their fragments coming from the photodegradation
(see Figures 1, 2 and 3)
Active principle Peak Retention time
Finasteride 1 5′ 25″
Diclofenac 1 6′ 30″
Diclofenac fragment 2 4′ 20″
Diclofenac fragment 3 5′ 55″
Naproxen 1 4′ 25″
Naproxen fragment 2 5′ 30″
Naproxen fragment 3 2′ 50″
Naproxen fragment 4 3′ 20″
Naproxen fragment 5 3′ 45″
Naproxen fragment 6 4′ 15″
Naproxen fragment 7 4′ 35″
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ity testing. To evaluate the radiant energy, a polycrystalline
photovoltaic panel was connected in series to a 20 Ohm
resistance and to a data logger, the voltage was then moni-
tored. The presence of the resistance was needed in order
to have the highest possible value of sensitivity of the
panel - δV/δ (W/m2). It corresponds to a high voltage
variation by the slightest variation of radiant energy. A
radiometer/luxmeter was placed near to the photovoltaic
panel and irradiance (W/m2) and illuminance (lux) were
measured at about 1 hour intervals from sunrise to sunset.
Voltage values, measured at the same times by the photo-
voltaic panel, were plotted against irradiance measured by
the radiometer/luxmeter; a straight line was obtained with
a slope of 250 ± 9 W ·m-2 · V-1, an intercept of 6.23 ±Figure 4 Trend of the Finasteride, Diclofenac and Naproxen concentr0.06 W ·m-2 and a good correlation coefficient (R2 =
0.9959) (Additional file 1: Figure S3). So, a curve of irradi-
ance was obtained from data collected by the data logger
during 24 hours (Figure 7).
Using the PeakFit v4.12 software, the value 2.76.107 J/m2
was obtained for the area below the curve. It corresponds
to the solar energy collected by the photovoltaic panel
over 24 hours of an average day (completely sunny) of July
and results very close to the one declared on the website
of the General Directorate of the European Commission -
Joint Research Centre (2.71.107 J/m2) [19] for a completely
July sunny day in Rome. Once established that collected
data are significant, the next step was the choice of the ir-
radiance to be used for the tests [20]. Basing on Figure 7,
an energy equal to 600 W/m2 was chosen that corre-
sponds to the minimum irradiation during the sunniest
hours. In such conditions, at least 22 hours of irradiation
are needed in order to comply with ICH guidelines (ex-
posure to not less than 1.2.106 lux.h and 200 W.h/m2).
Basing on what above said, in order to simulate at the
best the solar spectrum, the OSRAM ULTRA-VITALUX
[21] Sun Lamp was chosen for the photostability tests.
The lamp consists of a tungsten filament (IR-Vis range)
and a mercury-vapor lamp (UV range), (Additional file 1:
Figure S4). The distance of the source from the sample
was optimized in order to provide a value of 600 W/m2
that was measured at each sampling time in order to
control the lamp’s stability. Eventual sample degradation,
due to heating caused by the lamp, was minimized by
means of a cooling system providing a laminar air flow. In
such conditions, temperature and relative humidity, both
monitored by a Lascar Mod. EL-USB 2 data logger,
remained almost constant during the tests with valuesations during the photodegradation tests.
Table 3 Integral toxicity index of active pure principles





ΔI0 ΔI It = ΔI/ΔI0
Finasteride 0 3.26 ± 0.02 1.65 ± 0.02 0.51
90 3.46 ± 0.04 1.35 ± 0.03 0.39
Diclofenac 0 3.45 ± 0.02 2.66 ± 0.01 0.77
90 4.77 ± 0.02 2.25 ± 0.02 0.47
Naproxen 0 3.06 ± 0.01 2.35 ± 0.02 0.77
90 4.06 ± 0.03 0.55 ± 0.01 0.14
Values comes from at least 3 tests.
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conditions adopted for the photostability tests are re-
ported in Additional file 1: Table S1 of the EDF.
Integral toxicity test
An already widely applied method [22,23] was used in
order to determine the integral toxicity of both the consid-
ered active principles, and drugs containing them, first
and after the photodegradation tests. The respiratory ac-
tivity of Saccharomyces Cerevisiae suspended yeast cells
was evaluated by a Clark oxygen sensor in presence and
absence of the sample, an integral toxicity index was then
calculated taking into account the difference.
Shortly, 250 mg of yeast cells are suspended in 100 ml of
a 1 mol/l glucose aqueous solution (yeast nutrient), for at
least 2 hours, to optimize their respiratory activity. A Clark
oxygen electrode is then immerged in 10 ml of the previ-
ous solution in a thermostated at 25 ± 1°C cell and main-
tained under magnetic stirring till the stabilization of the
signal (usually between 7 and 8 ppm). 1 ml of the sample
solution is then added; a decrease of the respiratory func-
tion of the yeast, evidenced by an oxygen concentrationFigure 5 Comparison between photodegradation efficiency
(PDE) and reduction of the toxicity index (ItR) toxicity
abatement after 90 hours of exposure to simulated sunlight.
F: Finasteride, D: Diclofenc, N: Naproxen.increase until a new steady-state, is observed that results
proportional to the integral toxicity of the sample. The
integral toxicity index is calculated as It = ΔI / ΔIo (see
Figure 8). ΔIo is then due to the addition of the yeast so
being proportional to both the total number of the yeast
cells and their breathing activity while ΔI is bound to the
toxic activity of the sample (concentration and intrinsic
toxicity) but also to the number and viability of yeast cells;
so, the most accurate toxicity index results to be ΔI/ΔIo.
Photodegradation process
Photostability tests were initially carried out on aqueous so-
lutions of the three pure active principles in order to speed
up the process and to obtain kinetic information; further-
more, in such conditions we can also have a rough evalu-
ation of their persistence in natural water bodies where
they can enter (really at concentration of several order
lower than those we here tested) [10]. Solutions were ir-
radiated inside conical flasks of Pyrex England glass be-
cause its low absorption at wavelength higher than 320 nm
(Additional file 1: Figure S5) complies with ICH guidelines
for photostability testing. Irradiation was carried out for
90 hours and, at preset intervals, 0.5 ml aliquots were sam-
pled and stored in the dark until the analysis.
20 tablets of each drug were used for the photostability
test: 5 tablets were not radiated in order to use them as
reference (blank), while 5 tablets were exposed inside
the marketing pack (cardboard box), 5 tablets were ex-
posed inside the primary pack, 5 tablets were exposed by
removing all packaging, after a fine grinding and thin
layering on glass plate.
Calculations for photostability and toxicity test





where Af and Ai are the final and initial areas of the chro-
matographic peaks registered for the active principle.
Likewise the toxicity reduction (ItR) was calculated as
follows
ItR ¼ ItfIti  100
where Itf and Iti are the final and initial toxicity indexes,
calculated as above said.
Conclusions
Even if simple and cheap, the proposed procedure can be a
starting point to obtain useful information about the fate
of drugs entering the environment as a consequence of the
normal metabolic processes or bad wasting and so on; a
Figure 6 Photodegradation percentages obtained after 90 h irradiation for both pure active principles and drugs. F: Finasteride, D:
Diclofenc, N: Naproxen, P(F): Prostide (containing Finasteride), V(D): Voltaren (containing Diclofenac), M(N): Momendol (containing Naproxen);
mp: marketing package (cardboard), pp: primary package (plastic blister), np: no package (naked tablet). Data come from at least nine measures,
i.e. three measures on each solution obtained from three tests; SD%≤ 2.5.
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to take into account the very low concentration up today
found there [10]. On the contrary, the proposed procedure
can be of help in optimizing the process conditions adopted
in water treatment plants of pharmaceutical industries; in
such case, the concentration is enough high and its de-
crease need to be speeded up using, as an example, hetero-
geneous photocatalysis through UV irradiation catalyzed by
TiO2 that can be combined with visible and/or micro-
waves irradiation [24,25]. Also in these cases the couplingFigure 7 Average solar irradiance measured in Rome (Italy) during aof the two analytical techniques, HPLC and toxicity tests,
allows us to achieve the goal of obtaining data not only on
the photostability but also on non-specific toxicity of the
active ingredients and, though roughly, of the photodegra-
dation products. A nonspecific toxicity test is surely
more useful, at least for a first approach, than specific
ones; in addition, the use of yeast cells respects ethical
principles (no use of higher animals) and, especially, the
toxic effects on these cells result very similar to those
on human ones [26]. The three considered pure activeday on July.
Figure 8 Trends of the oxygen concentration during the toxicity test.
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quick photodegradation with estimated half-life times
equal to about 10, 30 and 100 h for Naproxen, Diclofe-
nac and Finasteride respectively. Regarding the drugs,
considered that following the ICH guidelines, we posed
in extreme conditions, data reveal that the excipients
exert a high protective effect against the degradation of
the active principle. Surely the marketing package ensure
an almost complete protection while, for tests performed
on the drug inside the primary pack, we cannot separate
the contribute of the excipients from that of the blister but,
anyway, especially for Naproxen, photodegradation occurs
at a significant level. Such data can be surely useful to es-
tablish the drug’s “expiration date” but, as above said, our
main goal was to also obtain toxicity data first and after
photodegradation. The toxicity order for the three pure ac-
tive principles results Diclofenac =Naproxen > Finasteride
luckily inverse with respect to their photostability. For all
the three considered drugs, the percentage toxicity reduc-
tion (ItR%) after the photodegradation resulted, at different
extent, lower than the photodegradation percentage (PD%)
so revealing a toxicity of the photodegradation products. In
particular looking at the Figure 5, it could be stated that
the toxicity of products coming from the photodegradation
of Naproxen are less toxic than those from Finasteride
that, in turn, are less toxic than those of Diclofenac but,
really such order is not reliable since their different photo-
stability surely plays a role in their toxicity.
What above said highlights the need for further research
to obtain complete information, i.e., the use of more ad-
vanced analytical techniques, a more detailed time trend
for the toxicity and so on.
Surely the topic is of great environmental interest be-
cause the drugs are pollutants that tend to increase inconcentration, due to both the aging of the population
and increase of industrial pollutants [27-29]. Their photo-
stability plays an important role in contrasting their own
pollution; as a fact, a low photostability let to a low envir-
onmental persistence but a complete toxicity abatement
can be attained only after their mineralization [30]. In our
tests, may be due to their not adequate irradiation time,
the solar light resulted not completely suitable can be so
useful in all the cases of unintentional leakage of drugs
while inside water treatment plants the process is con-
trolled and speeded up using, as an example, heteroge-
neous photocatalysis, by TiO2, combined with UV and
micro-waves irradiation [24,25]. Also in these cases the
proposed procedure can be of help in optimizing the
process conditions.Methods
Chemicals and drugs
Acetonitrile (99.9%), water plus (distilled water filtered at
2 μm) and methyl alcohol (99.9%), all of HPLC grade,
monobasic potassium phosphate (99.0%), orthophosphoric
acid (98%) from Carlo Erba Reagenti (Milan, Italy).
Finasteride (N-tert-Butyl-3-oxo-4-aza-5α-androst-1-
en-17β-carboxamide; ≥98%), Diclofenac Sodium Salt (2-
[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium
salt; ≥98%), Naproxen Sodium Salt ((S)-6-Methoxy-α-
methyl-2-naphthaleneacetic acid sodium salt; ≥98%)
from Sigma-Aldrich (Milan, Italy).
Momendol 220 tablets containing 220 mg of Naproxen
Sodium Salt (Aziende Chimiche Riunite SpA Francesco
Angelini, Italy), Prostide, tablets containing 5 mg of Finas-
teride (Sigma-Tau Industrie Farmaceutiche Riunite SpA,
Italy) and Voltaren 50, tablets containing 50 mg of
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purchased from several pharmacies in Rome, Italy.
All the three drugs are sold in cardboard boxes. The
immediate pack of Prostide and Momendol consists of
opaque white plastic, while the one of Voltaren consists
of transparent colourless plastic. All tablets are covered
by a polysaccharide film. The complete compositions are
listed in Additional file 1: Table S2 of the EDF.
Sample pre-treatment
All pure active principles were weighed by means of an
analytical balance (0.01 mg resolution) and solutions were
prepared using glass flasks of Class A grade. Diclofenac
and Naproxen were dissolved in ultrapure water, while for
Finasteride a 1:20 CH3CN/H2O mixture was used because
not enough soluble in water.
Tablets of drugs were finely ground in a porcelain
mortar and quantitatively racked in a centrifuge tube
together with about 6 ml of solvent; the centrifuge tubes
were sonicated for 5 minutes and then centrifuged at
10,000 rpm for 10 minutes in order to extract the active
principle; supernatants collected from three successive
extractions were brought to volume in a suitable flask
and analysed by HPLC.
Instruments
The HPLC equipment consists of a Kontron pump mod.
422, with head pump mod. 420, a Rheodyne valve injec-
tion mod. 7125, a 20 μl loop, a Kontron UV/VIS detector
mod. 430 connected to a data logger (Pico Technology -
Mod. Dr. Daq), a PC equipped with the softwares PicoLog
v5.16.2 and PeakFit v4.12. An Alltech reversed phase col-
umn (mod. Alltima C8 250 x 4.6 mm I.D.) filled with par-
ticles of 5 μm of diameter was used as stationary phase
while a mixture of Acetonitrile/Water 95:5 was used as
eluent for Finasteride and a mixture of pH 3.3 phosphate
buffer/Acetonitrile/Methyl alcohol 30:35:35 for Diclofenac
and Naproxen.
A Perkin-Elmer mod. Lambda 16 spectrophotometer
was used to select the wavelength to be set for the HPLC
detector.
Temperature was maintained at 25 ± 1°C using a All-
tech 330 Column Heater thermostatic bath in which the
column was immersed.
A radiometer/luxmeter Gossen - model Mavolux Digital
was used for the measures of irradiance, illuminance and
radiant energy while temperature and humidity were
monitored by a data logger Lascar - model EL-USB 3.
The equipment for the Toxicity test consists of a glass
thermostated cell; a Clark oxygen electrode Orion 97–08
(Thermo Electron Corporation); an Orion Microproces-
sor Ionalyzer/901 potentiometer; an Amel Model 868 re-
corder. Saccharomyces cerevisie yeast cells were used as
biological mediator.HPLC analysis
The wavelength for the HPLC’s UV detector was chosen
basing on the UV/Vis absorption spectra of the pure active
principles (Additional file 1: Figure S2): 205 nm for Finas-
teride, 275 nm for Diclofenac and 262 nm for Naproxen.
Spectra were acquired in the suitable solvents i.e. the one
used as mobile phases for the HPLC analyses. Calibration
curves were built not only to follow the photodegradation,
but also to test the linear range for each active principle;
basing on their lower value, we choose the initial concen-
tration of the pure active principles to be subjected to
photodegradation; the criterion was that, after a 90% of
photodegradation, the residual concentration had to be
appreciated. Additional file 1: Table S3 of EDF summarizes
the experimental condition adopted for the analysis as well
as the main analytical parameters of the calibration curves
obtained for the three active principles.
Additional file
Additional file 1: Figure S1. Formulas of the three considered active
principles. Figure S2. UV/Vis spectra of the three considered active
principles. The wavelengths chosen to set the detector are evidenced.
Figure S3. Correlation between values of tension generated by
photovoltaic panel and those ones of radiance measured by radiometer/
luxmeter. Figure S4. Emission spectra of the Osram Ultra-Vitalux lamp.
Figure S5. UV/Vis spectrum of the glass constituting the flask used for
the photodegradation tests on pure active principles. Table S1.
Experimental conditions adopted for the photostability test. Table S2.
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